Response to Carfilzomib Therapy

1
Response to Carfilzomib Therapy
Response category All patients (n257) Patients with baseline PN (n202)
Complete response (CR) 0.4 0.4
Very good partial response (VGPR) 5.1 5.1
Partial response (PR) 18.7 18.3
Minimal response (MR) 10.1 10
Stable disease (SD) 34.6 28.2
Progressive disease (PD) 26.8 33.1
Not Evaluable by IRC 4.4 5
Overall response rate (ORR) 24.1 23.7
Clinical benefit response (CBRORR MR) 34.2 33.7
Responses as assessed by the Independent Response Committee (IRC) PN peripheral neuropathy Responses as assessed by the Independent Response Committee (IRC) PN peripheral neuropathy Responses as assessed by the Independent Response Committee (IRC) PN peripheral neuropathy
985